We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$339M
AUM Growth
+$46.9M
Cap. Flow
+$46.4M
Cap. Flow %
13.68%
Top 10 Hldgs %
57.14%
Holding
1,272
New
528
Increased
234
Reduced
146
Closed
296

Sector Composition

Rank Sector Weight
1 Communication Services 19.51%
2 Healthcare 17.13%
3 Technology 11.03%
4 Financials 6.4%
5 Industrials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRST icon
301
Primis Financial Corp
FRST
$402M
$76K 0.02%
+5,001
New +$73.7K
NRK icon
302
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$916M
$76K 0.02%
+5,816
New +$75.2K
PEP icon
303
PepsiCo
PEP
$188B
$76K 0.02%
+585
New +$75K
ELS icon
304
Equity Lifestyle Properties
ELS
$12.5B
$75K 0.02%
+1,248
New +$73.9K
BPYU
305
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$75K 0.02%
4,000
-244,180
-98% -$4.86M
GNC
306
DELISTED
GNC Holdings, Inc.
GNC
$75K 0.02%
50,000
+25,000
+100% +$47.4K
BFZ
307
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$73K 0.02%
5,536
+5,323
+2,499% +$69.5K
CYRX icon
308
CryoPort
CYRX
$747M
$73K 0.02%
4,000
-9,000
-69% -$143K
NLY icon
309
Annaly Capital Management
NLY
$17.3B
$73K 0.02%
+2,000
New +$76.2K
GILD icon
310
Gilead Sciences
GILD
$165B
$72K 0.02%
+1,069
New +$70.3K
APHA
311
DELISTED
Aphria Inc. Common Shares
APHA
$72K 0.02%
+10,400
New +$78.7K
DBX icon
312
Dropbox
DBX
$8.07B
$71K 0.02%
+2,873
New +$66.4K
GDL
313
GDL Fund
GDL
$91.9M
$71K 0.02%
+7,793
New +$72.8K
UVXY icon
314
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
$71K 0.02%
+1
New +$88.2K
ATEX icon
315
Anterix
ATEX
$1.81B
$70K 0.02%
1,500
-500
-25% -$21.1K
BBN icon
316
BlackRock Taxable Municipal Bond Trust
BBN
$984M
$70K 0.02%
2,983
-8,017
-73% -$185K
SILK
317
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$70K 0.02%
+1,458
New +$62K
ASPU
318
DELISTED
ASPEN GROUP, INC.
ASPU
$70K 0.02%
18,464
+2,500
+16% +$10.9K
JHY
319
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
$70K 0.02%
7,103
+6,961
+4,902% +$69.2K
CENTA icon
320
Central Garden & Pet Co Class A
CENTA
$2.39B
$68K 0.02%
3,500
-125
-3% -$2.51K
KTF
321
DWS Municipal Income Trust
KTF
$352M
$68K 0.02%
+6,079
New +$67.7K
PH icon
322
Parker-Hannifin
PH
$134B
$68K 0.02%
+400
New +$69K
SSRM icon
323
SSR Mining
SSRM
$6.4B
$68K 0.02%
5,000
+4,750
+1,900% +$56.6K
VIAB
324
DELISTED
Viacom Inc. Class B
VIAB
$68K 0.02%
2,303
+1,893
+462% +$55.3K
PACB icon
325
Pacific Biosciences
PACB
$357M
$67K 0.02%
11,200
+7,600
+211% +$53.3K

Similar funds

FNY Investment Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, FNY Investment Advisers held 1,272 positions worth $339M, up 16% from $292M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

FNY Investment Advisers deployed $46.4M of net new capital in Q2 2019, opening 528 new positions and adding to 234 existing holdings. Its largest new stake was InflaRx: 280,000 shares worth $884K.

By sector, the portfolio is most concentrated in Communication Services at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $21.7M trimmed.

  • FNY Investment Advisers's largest Q2 2019 buy was InflaRx: 280,000 shares worth $884K.
  • FNY Investment Advisers added most to Anadarko Petroleum in Q2 2019, an estimated $46.5M increase.
  • FNY Investment Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $21.7M.
  • FNY Investment Advisers fully exited Coty in Q2 2019, selling an estimated $24.3M.
  • FNY Investment Advisers's ten largest holdings make up 57% of its $339M portfolio in Q2 2019.
  • FNY Investment Advisers opened 528 new positions and closed 296 in Q2 2019.
  • FNY Investment Advisers's portfolio value rose 16% quarter-over-quarter to $339M.

Based on FNY Investment Advisers's 13F filing for Q2 2019, filed 24 Jul 2019.